These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15940257)

  • 21. Comparison between properties of 2'-O,4'-C-ethylene-bridged nucleic acid (ENA) phosphorothioate oligonucleotides and N3'-P5' thiophosphoramidate oligonucleotides.
    Horie M; Morita K; Kawakami J; Ando O; Koizumi M; Tsutsumi S
    Nucleosides Nucleotides Nucleic Acids; 2006 Mar; 25(3):231-42. PubMed ID: 16629117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR.
    Bajpai AK; Park JH; Moon IJ; Kang H; Lee YH; Doh KO; Suh SI; Chang BC; Park JG
    Oncogene; 2005 Sep; 24(43):6492-501. PubMed ID: 16170384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imetelstat (a telomerase antagonist) exerts off‑target effects on the cytoskeleton.
    Mender I; Senturk S; Ozgunes N; Akcali KC; Kletsas D; Gryaznov S; Can A; Shay JW; Dikmen ZG
    Int J Oncol; 2013 May; 42(5):1709-15. PubMed ID: 23545855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of telomerase activity of melanoma cells in vitro by antisense oligonucleotides.
    Glukhov AI; Zimnik OV; Gordeev SA; Severin SE
    Biochem Biophys Res Commun; 1998 Jul; 248(2):368-71. PubMed ID: 9675142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telomerase inhibition with an oligonucleotide telomerase template antagonist: in vitro and in vivo studies in multiple myeloma and lymphoma.
    Wang ES; Wu K; Chin AC; Chen-Kiang S; Pongracz K; Gryaznov S; Moore MA
    Blood; 2004 Jan; 103(1):258-66. PubMed ID: 12969977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allosteric inhibitors of telomerase: oligonucleotide N3'-->P5' phosphoramidates.
    Pruzan R; Pongracz K; Gietzen K; Wallweber G; Gryaznov S
    Nucleic Acids Res; 2002 Jan; 30(2):559-68. PubMed ID: 11788719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retraction: Effects of Oligonucleotide N3'→P5' Thio-phosphoramidate (GRN163) Targeting Telomerase RNA in Human Multiple Myeloma Cells.
    Akiyama M; Hideshima T; Shammas MA; Hayashi T; Hamasaki M; Tai YT; Richardson P; Gryaznov S; Munshi NC; Anderson KC
    Cancer Res; 2024 Mar; 84(6):937. PubMed ID: 38486483
    [No Abstract]   [Full Text] [Related]  

  • 28. New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.
    Hashizume R; Ozawa T; Gryaznov SM; Bollen AW; Lamborn KR; Frey WH; Deen DF
    Neuro Oncol; 2008 Apr; 10(2):112-20. PubMed ID: 18287341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of telomerase activity by preventing proper assemblage.
    Keppler BR; Jarstfer MB
    Biochemistry; 2004 Jan; 43(2):334-43. PubMed ID: 14717587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of telomerase activity and telomere length to chemosensitivity.
    Kiyozuka Y
    Methods Mol Med; 2005; 111():97-108. PubMed ID: 15911975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telomerase inhibitor GRN163L inhibits myeloma cell growth in vitro and in vivo.
    Shammas MA; Koley H; Bertheau RC; Neri P; Fulciniti M; Tassone P; Blotta S; Protopopov A; Mitsiades C; Batchu RB; Anderson KC; Chin A; Gryaznov S; Munshi NC
    Leukemia; 2008 Jul; 22(7):1410-8. PubMed ID: 18449204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein and RNA of human telomerase as targets for modified oligonucleotides.
    von Janta-Lipinski M; Gaertner K; Lehmann C; Scheer H; Schildt J; Matthes E
    Nucleosides Nucleotides; 1999; 18(6-7):1719-20. PubMed ID: 10474255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha-Oligodeoxyribonucleotide N3'-->P5' phosphoramidates: synthesis and duplex formation.
    Pongracz K; Gryaznov SM
    Nucleic Acids Res; 1998 Feb; 26(4):1099-106. PubMed ID: 9461474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antisense oligonucleotides with antitumor activity].
    Otvös L; Sági G
    Magy Onkol; 2004; 48(3):221-7. PubMed ID: 15520872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin inhibits telomerase activity in human cancer cell lines.
    Cui SX; Qu XJ; Xie YY; Zhou L; Nakata M; Makuuchi M; Tang W
    Int J Mol Med; 2006 Aug; 18(2):227-31. PubMed ID: 16820928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RNA mimetics: oligoribonucleotide N3'-->P5' phosphoramidates.
    Gryaznov SM; Winter H
    Nucleic Acids Res; 1998 Sep; 26(18):4160-7. PubMed ID: 9722635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Telomerase RNA antisense oligonucleotides inhibit growth of human choriocarcinoma xenograft in nude mice].
    Chen LL; Zheng W; Chen XJ; Wan L; Shi YF
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):90-2. PubMed ID: 15946546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
    Wang X; Wang G; Dong D; Fu S; Yang B
    Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate.
    Kondo Y; Kondo S
    Methods Mol Biol; 2007; 405():97-112. PubMed ID: 18369820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.